The clinical discovery of imipramine

American Journal of Psychiatry

Volumn 172, Issue 5, 2015, Pages 426-429

  Brown, Walter A ^a   Rosdolsky, Maria ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; IMIPRAMINE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL OBSERVATION; CLINICAL RESEARCH; DEPRESSION; DRUG DEVELOPMENT; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOANALYSIS; PSYCHODYNAMICS; PSYCHOTHERAPY; REVIEW; SWISS; DEPRESSIVE DISORDER; HISTORY; SWITZERLAND;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DRUG DISCOVERY; HISTORY, 20TH CENTURY; HUMANS; IMIPRAMINE; SWITZERLAND;

EID: 84928943235     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.14101336     Document Type: Review

References (5)

1. Kuhn R: Über die Behandlung depressiver Zustände mit einem Iminodibenzylderival (G22355). Schweiz Med Wochenschr 1957; 87: 1135-1140
2. Healy D: The Antidepressant Era. Cambridge, Mass, Harvard University Press, 1997, pp 48-59
3. Ban TA, Healy D, Shorter E (eds): The imipramine dossier, in From Psychopharmacology to Neuropsychopharmacology in the 1980s and the Story of CINP. Edited by Ban TA, Healy D, Shorter E. East Kilbride, Scotland, CINP, 2010, pp 282-353
4. Healy D: The Psychopharmacologists, II. London, Arnold, 1998, pp 93-118
5. Salzman C: Interview with Jonathan O Cole, in An Oral History of Neuropsychopharmacology: The First Fifty Years, Peer Interviews, vol 10. Edited by Katz MM and Ban TA. Brentwood Tenn, American College of Neuropsychopharmacology, 2011, p 47